Trial intelligence / Profile preview

Apixaban level among Thai patients with non-valvular atrial fibrillation

TCTR20210311005Phase 3Enrolling by invitation

Sponsor
Faculty of Pharmacy, Silpakorn University
Start
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of apixaban in Atrial fibrillation (AFib), sponsored by Faculty of Pharmacy, Silpakorn University. Started Dec 2020; status: enrolling by invitation.

02

Drugs

apixaban
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on TCTR20210311005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210311005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call